Mengqing Li
Papers
1
Total Citations
12
H-Index
1
About
Dr. Mengqing Li is a leading surgical oncologist whose research focuses on optimizing treatment strategies for rectal cancer, particularly through the integration of neoadjuvant chemoradiotherapy (nCRT) and advanced surgical techniques. Dr. Li’s most cited work, a 2019 systematic review and Bayesian network meta-analysis, provides a rigorous comparative evaluation of open, laparoscopic, and robotic surgery outcomes following nCRT. This landmark study, with 12 citations, synthesizes evidence from randomized controlled trials to clarify the short- and long-term benefits of each approach, offering crucial guidance for clinical decision-making in a field where surgical precision directly impacts patient survival and quality of life. By employing advanced statistical methods to compare complex treatment pathways, Dr. Li has helped bridge the gap between evolving surgical technologies and evidence-based practice. This contribution is particularly valuable for surgeons and oncologists navigating the trade-offs between minimally invasive techniques and oncologic safety. Dr. Li’s work underscores a commitment to improving rectal cancer care through methodologically rigorous synthesis of clinical data, positioning them as a key voice in the ongoing refinement of multimodal treatment protocols.
Research Focus
Key Achievements
Top Papers
- 1